Yongyi Wang
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Hydrogen sulfide-mediated protein s-persulfidation: a regulatory mechanism in cardiovascular homeostasis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: April 13, 2026
Assessment of left atrioventricular coupling index in hypertrophic cardiomyopathy: improving risk stratification with cardiac magnetic resonance (CMR).
Journal: Clinical radiology
Published: November 26, 2025
BMAL1 attenuates myocardial infarction-induced fibrosis via suppressing p-SMAD3/SMAD3 in TGF-β1 pathway.
Journal: Biochemistry and biophysics reports
Published: November 16, 2025
Uridine-Cytidine Kinase 2 (UCK2)/Uridine-Cytidine Kinase Like 1 (UCKL1) complex exacerbates the differentiation of myocardial fibroblasts via TRIM21/Smurf2/Smad3 pathway after myocardial infarction.
Journal: Molecular biomedicine
Published: June 09, 2025
Correction: An antioxidant nanozyme for targeted cardiac fbrosis therapy post myocardial infarction.
Correction: An antioxidant nanozyme for targeted cardiac fbrosis therapy post myocardial infarction.
Journal: Journal of nanobiotechnology
Published: March 17, 2025
An antioxidant nanozyme for targeted cardiac fibrosis therapy post myocardial infarction.
Journal: Journal of nanobiotechnology
Published: July 24, 2024
Fractal analysis of left ventricular trabeculae in heart failure with preserved ejection fraction patients with multivessel coronary artery disease.
Journal: Insights into imaging
Published: February 03, 2024
Rare and common coding variants in lipid metabolism-related genes and their association with coronary artery disease.
Journal: BMC cardiovascular disorders
Published: May 18, 2023
Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy.
Journal: Insights into imaging
Published: April 30, 2023
microRNA-130b-3p Attenuates Septic Cardiomyopathy by Regulating the AMPK/mTOR Signaling Pathways and Directly Targeting ACSL4 against Ferroptosis.
Journal: International journal of biological sciences
Published: December 31, 2022
Corrigendum: Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway.
Journal: Frontiers in pharmacology
Published: April 06, 2022
Association of lipid metabolism-related gene promoter methylation with risk of coronary artery disease.
Journal: Molecular biology reports
Published: February 08, 2022
Last Updated: 09/26/2026